Form 483

Seaway Pharma Inc. Form 483, 2019-07-25

FDA issued a Form 483 to Seaway Pharma Inc. on 2019-07-25 with 4 public-safe observations.

483· Form 483 issuedFoods & Cosmetics4 observations

Seaway Pharma Inc. · Massena, United States · Issued July 25, 2019

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 Jul 2019
21 CFR 111.70(b)(3)

Specifications - contamination limits

Cited by Gerard D Difiore

25 Jul 2019
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Gerard D Difiore

25 Jul 2019
21 CFR 111.70(b)(3)

Specifications - contamination limits

Cited by Gerard D Difiore

25 Jul 2019
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Gerard D Difiore

Inspected site

SPSeaway Pharma Inc.Massena, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.70(b)(3)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere